About the Journal
Aims & Scope | Audience | Review Process | Editorial Team | About the Editors | Facts about the Journal | Benefits | Abstracting and Indexing Information | Journal Ethics | Plagiarism Policy | Archival Policy | Open Access Publication and Creative Commons Licensing | Ahead of Print Policy | Advertisements | Subscription Information | Publisher
The Global Journal of Medical Pharmaceutical and Biomedical Update (GJMPBU) (formerly known as Internet Journal of Medical Update, E-ISSN 1694-0423) is an open-access peer-reviewed journal committed to publishing high-quality articles in the field of Biomedicine, Surgery and Pharmacology. The journal is owned by Dr. Vipul Yagnik (owner) & Dr. Okezie Aruoma, Dr. Arun Kumar Agnihotri (co-owners) and published by the Scientific Scholar.
Aims & Scope
Journal provides a multidisciplinary forum for the exchange of current ideas in the form of original research work, review article, interesting case report, brief communication, letter to the editor etc. among medical professionals. It is also intended to provide a platform for young medical professionals to participate in research activities, with the aim to enhance their outlook towards recent developments in the field of medicine. Being multidisciplinary in nature, all students undergoing medical training would be benefited from the scientific publications of this journal.
Our audience includes all the practitioners of Biomedicine, Surgery and Pharmacology.
The Global Journal of Medical Pharmaceutical and Biomedical Update (GJMPBU) has a highly rigorous double-blinded peer-review process that makes sure that manuscripts are scientifically accurate, relevant, novel and important. Authors disclose all conflicts of interest, affiliations and financial disclosures such that the published content is not biased.
In-house submissions that contain the work of any editorial board member, are not allowed to be reviewed by that editorial board member and all decisions regarding this manuscript are made by an independent editor. In addition, these manuscripts are reviewed by the two external reviewers. This is also disclosed in the published manuscript under the section of Conflict of Interest.
The editorial board comprises a panel of experts in Biomedicine, Surgery and Pharmacology from various countries to provide their expertise and guidance to the Editor-In-Chief in maintaining the clarity of content and focus of the journal’s purpose.
About the Editor
Dr. Vipul Yagnik (Medical Science)
Director and Consultant Surgical Gastroenterologist,
Nishtha Surgical Hospital and Research,
Patan, Gujarat, India
Email: email@example.com; firstname.lastname@example.org
Dr. Okezie I Aruoma (Pharmaceutical and Biomedical Science)
President and Chief Executive Officer,
Global PharmHealth Investors Inc.,
Long Beach, CA 90809, USA
Founder Editor and Managing Editor
Dr. Arun Kumar Agnihotri
Professor of Pathophysiology,
American University of Antigua College of Medicine,
Antigua and Barbuda, WI
Facts about the Journal
The Global Journal of Medical Pharmaceutical and Biomedical Update (GJMPBU) is a peer-reviewed international journal with a double-blind review process. Its frequency of publication is continuous. The Global Journal of Medical Pharmaceutical and Biomedical Update (GJMPBU) is published in E-Journal format and the journal is also available in print on demand.
A manuscript published in the Global Journal of Medical Pharmaceutical and Biomedical Update (GJMPBU) can be read and downloaded by readers all over the world without any charges or fees. The author retains the copyright of the manuscript and the figures. This allows authors to extend their exposure in the world of medical research and get worldwide recognition for their work.
Abstracting and Indexing Information
The journal is indexed with, or included in, the following:EMBASE/Excerpta Medica, Emerging Sources Citation Index (ESCI), UGC-CARE List (India)
The journal is registered with the following abstracting partners:
Google Scholar, Index Copernicus, EBSCO Publishing’s Electronic Databases, Scilit, China National Knowledge Infrastructure (CNKI), Wang Fung, ReadCube
The Global Journal of Medical Pharmaceutical and Biomedical Update (GJMPBU) is committed to meeting and upholding ethical guidelines at all stages of the publication process. We follow the industry associations, such as the Committee on Publication Ethics (COPE), the International Committee of Medical Journal Editors (ICMJE), and the World Association of Medical Editors (WAME), that set standards and provide guidelines for best practices to meet these requirements. For a summary of our specific policies regarding duplicate publication, conflicts of interest, patient consent, etc., please visit our Ethical Guidelines Section.
We provide plagiarism check software (iThenticate) on the Editor’s and Reviewer’s panel in the manuscript management system. We encourage our editors and reviewers to use the plagiarism check. The manuscript’s found to have plagiarism is rejected.
Open Access Publication and Creative Commons Licensing
Global Journal of Medical, Pharmaceutical, and Biomedical Update is an open-access journal, and manuscripts published are distributed under the terms of the Creative Commons Attribution-Non Commercial-Share Alike 4.0 License (CC-BY-NC-SA 4.0), which allows others to remix, transform, and build upon the work non-commercially, as long as appropriate credit is given and the new creations are licensed under the identical terms.
Ahead of Print Policy
The Global Journal of Medical Pharmaceutical and Biomedical Update (GJMPBU) is a continuous publication.
While advertisements are crucial to this journal to be able to keep all content free for everyone, ethical considerations are in place (https://scientificscholar.com/adv-policies/) to ensure the integrity of the journal and its content are not biased or influenced by the advertisement.
“Pop-up” and “Banner” advertisement appears at a fixed location on the page and does not interfere with the reading/display of the manuscript in any form (https://gjmpbu.org/advertise).
All advertisements are approved in consultation with Editor-In-Chief/the Editorial Board.
Advertisers submit their advertisements without prior information of the journal content to be published.
The Global Journal of Medical Pharmaceutical and Biomedical Update (GJMPBU) is a continuous publication and published manuscripts in the journal can be read and downloaded by readers all over the world without any charges or fees.
The journal is published in E-Journal format and the journal is also available in print on demand. Journal also offers a Print-on-Demand subscription – https://scientificscholar.com/buy-subscriptions/.
Imaging Science Today was founded in 2011 by a group of practicing doctors and industry specialists, it changed its name to Scientific Scholar LLC, USA (scientificscholar.com). All the scientific journal publishing of Imaging Science Today was brought under the umbrella of Scientific Scholar LLC in 2017. Scientific Scholar LLC (scientificscholar.com) is a well-respected medical publisher that fully supports open access publishing models, Subscription and Society based journal models through its peer-review management system – EditorialAssist (journalmanagement.org). The head office of Scientific Scholar (scientificscholar.com) is in Rochester, NY, USA and has a subsidiary arm in India.
Scientific Scholar (scientificscholar.com) owns its Manuscript Management System called EditorialAssist (journalmanagement.org). This system is very intuitive with a very short learning curve. The overall functionality of this system is based on “DRAG AND DROP”.
The mission of the Scientific Scholar (scientificscholar.com) is “Share, Learn and Improve”.
Scientific Scholar (scientificscholar.com) currently publishes many prestigious and indexed journals like the Journal of Clinical Imaging Science (clinicalimagingscience.org), Surgical Neurology International (surgicalneurologyint.com), CytoJournal (cytojournal.com) and many more (scientificscholar.com/journals). Scientific Scholar (scientificscholar.com) currently publishes approximately thirty three peer-reviewed journals.